Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating) and Repligen (NASDAQ:RGEN – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Risk and Volatility Acumen Pharmaceuticals has a beta of -1.55, suggesting […]
Repligen (NASDAQ:RGEN – Get Rating) and Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Analyst Recommendations This is a summary of recent ratings and recommmendations […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) and Sernova (OTCMKTS:SEOVF – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares Alnylam Pharmaceuticals and Sernova’s net margins, return […]
Repligen (NASDAQ:RGEN – Get Rating) and Molecular Partners (NASDAQ:MOLN – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. Institutional and Insider Ownership 91.0% of Repligen shares are held by […]
Leerink Partners Maintains a Hold Rating on Alnylam Pharma (ALNY) markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.